Stem cell transplantation for autoimmune diseases.

PubWeight™: 0.83‹?›

🔗 View Article (PMC 2817019)

Published in Haematologica on February 01, 2010

Authors

Thomas Hügle, Thomas Daikeler

Articles cited by this

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science (2002) 12.75

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet (2004) 11.77

C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA (2009) 4.13

Developmental kinetics and lifespan of dendritic cells in mouse lymphoid organs. Blood (2002) 3.19

Autologous hematopoietic stem cell transplantation in patients with refractory Crohn's disease. Gastroenterology (2005) 2.85

Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system. Blood (2008) 2.59

Autologous haematopoietic stem cell transplantation fails to stop demyelination and neurodegeneration in multiple sclerosis. Brain (2007) 2.46

Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus. JAMA (2006) 2.34

Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients. J Exp Med (2005) 2.30

Treatment of systemic sclerosis with autologous haemopoietic stem cell transplantation. Lancet (1997) 1.76

Nonmyeloablative stem cell transplant in a patient with advanced systemic sclerosis and systemic lupus erythematosus. J Rheumatol (2004) 1.69

Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases. Haematologica (2009) 1.65

Autologous hematopoietic stem cell transplantation for autoimmune diseases. Bone Marrow Transplant (2005) 1.37

Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry. Ann Rheum Dis (2004) 1.30

Allogeneic hematopoietic SCT for patients with autoimmune diseases. Bone Marrow Transplant (2009) 1.28

Autologous stem cell transplantation for systemic lupus erythematosus. Lupus (2004) 1.24

Multipotent mesenchymal stromal cells for autoimmune diseases: teaching new dogs old tricks. Bone Marrow Transplant (2009) 1.24

Autologous bone marrow transplantation in autoimmune arthritis restores immune homeostasis through CD4+CD25+Foxp3+ regulatory T cells. Blood (2008) 1.22

Skin involvement in scleroderma--where histological and clinical scores meet. Rheumatology (Oxford) (2007) 1.20

Clinically demonstrable anti-autoimmunity mediated by allogeneic immune cells favorably affects outcome after stem cell transplantation in human autoimmune diseases. Bone Marrow Transplant (2002) 1.15

The role of innate immunity in autoimmune tissue injury. Curr Opin Rheumatol (2008) 1.06

Analysis of immune reconstitution after autologous bone marrow transplantation in systemic sclerosis. Arthritis Rheum (2005) 1.05

Why do we need noncommercial, investigator-initiated clinical trials? Nat Clin Pract Rheumatol (2008) 1.01

Rapid improvement of nailfold capillaroscopy after intense immunosuppression for systemic sclerosis and mixed connective tissue disease. Ann Rheum Dis (2008) 1.00

Apoptosis and complement-mediated lysis of myeloma cells by polyclonal rabbit antithymocyte globulin. Blood (2005) 0.97

Allogeneic bone marrow transplantation (BMT) for refractory Behçet's disease with severe CNS involvement. Bone Marrow Transplant (2006) 0.95

Refractory Evans' syndrome treated with allogeneic SCT followed by DLI. Demonstration of a graft-versus-autoimmunity effect. Bone Marrow Transplant (2003) 0.94

Haematopoietic stem cell transplantation for vasculitis including Behcet's disease and polychondritis: a retrospective analysis of patients recorded in the European Bone Marrow Transplantation and European League Against Rheumatism databases and a review of the literature. Ann Rheum Dis (2006) 0.94

High-dose cyclophosphamide without stem cell rescue in scleroderma. Ann Rheum Dis (2007) 0.93

Long-term outcome of autoimmune disease following allogeneic bone marrow transplantation. Arthritis Rheum (1998) 0.93

Non-myeloablative allogeneic hematopoietic stem cell transplantation for severe systemic sclerosis: graft-versus-autoimmunity without graft-versus-host disease? Bone Marrow Transplant (2007) 0.93

How to cope with pathogenic long-lived plasma cells in autoimmune diseases. Ann Rheum Dis (2008) 0.87

Hematopoietic stem cell transplantation in multiple sclerosis. Acta Neurol Scand (2009) 0.81

Articles by these authors

Erectile dysfunction is frequent in systemic sclerosis and associated with severe disease: a study of the EULAR Scleroderma Trial and Research group. Arthritis Res Ther (2012) 1.44

Functional properties of a monoclonal antibody inhibiting the hepatitis C virus RNA-dependent RNA polymerase. J Biol Chem (2001) 1.19

The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis. Eur J Nucl Med Mol Imaging (2011) 1.12

The value of serum procalcitonin level for differentiation of infectious from noninfectious causes of fever after orthopaedic surgery. J Bone Joint Surg Am (2010) 1.08

T cells in systemic sclerosis: a reappraisal. Rheumatology (Oxford) (2012) 1.05

Educational quality of YouTube videos on knee arthrocentesis. J Clin Rheumatol (2013) 1.02

Management of autoimmune diseases after haematopoietic stem cell transplantation. Br J Haematol (2012) 0.99

Interleukin-6, its role in fibrosing conditions. Cytokine Growth Factor Rev (2012) 0.96

Vascular involvement in patients with giant cell arteritis determined by duplex sonography of 2x11 arterial regions. Ann Rheum Dis (2010) 0.96

Biomechanics and pathomechanisms of osteoarthritis. Swiss Med Wkly (2012) 0.95

Late altered organ function in very long-term survivors after allogeneic hematopoietic stem cell transplantation: a paired comparison with their HLA-identical sibling donor. Haematologica (2010) 0.93

Synovial fluid metabolomics in different forms of arthritis assessed by nuclear magnetic resonance spectroscopy. Clin Exp Rheumatol (2012) 0.92

Toll-like receptor-mediated, enhanced production of profibrotic TIMP-1 in monocytes from patients with systemic sclerosis: role of serum factors. Ann Rheum Dis (2012) 0.91

Ankle osteoarthritis: etiology, diagnostics, and classification. Foot Ankle Clin (2013) 0.87

Differentiation potential of CD14+ monocytes into myofibroblasts in patients with systemic sclerosis. PLoS One (2012) 0.86

Autologous hematopoietic stem cell transplantation for autoimmune diseases. Acta Haematol (2005) 0.82

Physical and not mental health is impaired in very long-term survivors after HSCT compared with their respective donors: a paired analysis. Blood (2008) 0.82

Streptococcal hypersensitivity reloaded: severe inflammatory syndrome in Behcet's disease following 23-valent polysaccharide Streptococcus pneumoniae vaccine. Rheumatology (Oxford) (2011) 0.81

Giant cell arteritis followed by idiopathic retroperitoneal fibrosis in the same patient--an unexpected positron emission tomography finding. Rheumatology (Oxford) (2012) 0.80

Late-onset systemic sclerosis--a systematic survey of the EULAR scleroderma trials and research group database. Rheumatology (Oxford) (2010) 0.80

Lymphocyte counts in patients with ANCA-associated vasculitis. Rheumatol Int (2008) 0.78

New onset of myasthenia gravis after treatment of systemic sclerosis by autologous hematopoietic stem cell transplantation: sustained autoimmunity or inadequate reset of tolerance? Hum Immunol (2010) 0.77

A metabolic cause of spinal deformity. Metabolism (2009) 0.76

Three cases of primary small vessel vasculitis of the skeletal muscle-an own entity. BMJ Case Rep (2011) 0.75

Mycophenolate mofetil for the treatment of autoimmune diseases: hype or hope? Swiss Med Wkly (2009) 0.75

Nail fold capillaroscopy differs widely between systemic sclerosis and chronic graft vs host disease of the skin. Rheumatology (Oxford) (2011) 0.75

Alterations of skeletal muscle microcirculation detected by blood oxygenation level-dependent MRI in a patient with granulomatosis with polyangiitis. Rheumatology (Oxford) (2012) 0.75

[In Process Citation]. Ther Umsch (2016) 0.75

Cell-to-cell contact of activated mast cells with fibroblasts and lymphocytes in systemic sclerosis. Ann Rheum Dis (2012) 0.75

Synostosis of the sacroiliac joint as a developmental variant, or ankylosis due to sacroiliitis? Arthritis Rheumatol (2014) 0.75

Images in clinical medicine. Chronic venous insufficiency and dystrophic subcutaneous calcification. N Engl J Med (2008) 0.75

Painful swollen distal interphalangeal joints are not always Heberden's nodes! Arthritis Rheumatol (2014) 0.75

A confusing patient's history: small or large vessel vasculitis? Rheumatol Int (2009) 0.75

Minimal T-cell requirements for triggering haemophagocytosis associated with Epstein-Barr virus-driven B-cell proliferation: a clinical case study. Ann Rheum Dis (2011) 0.75

Bone marrow histology in a patient with fever of unknown origin. J Rheumatol (2008) 0.75

Dominant Epstein-Barr virus-specific T-cell responses are maintained during moderate and intense immunosuppressive treatment. Ann Rheum Dis (2010) 0.75

Peripheral monocytosis as a predictive factor for adverse outcome in the emergency department: Survey based on a register study. Medicine (Baltimore) (2017) 0.75

On the 2-electron 3-center B-H-B bond: charge density determination of tetraborane(10). Inorg Chem (2008) 0.75